Search

Your search keyword '"Piro Agostino"' showing total 159 results

Search Constraints

Start Over You searched for: Author "Piro Agostino" Remove constraint Author: "Piro Agostino"
159 results on '"Piro Agostino"'

Search Results

1. The impact of vaccination status on post-acute sequelae in hospitalized COVID-19 survivors using a multi-disciplinary approach: An observational single center study

4. A mobile app for improving the compliance with remote management of patients with cardiac implantable devices: a multicenter evaluation in clinical practice

5. Age-related differences and associated mid-term outcomes of subcutaneous implantable cardioverter-defibrillators: A propensity-matched analysis from a multicenter European registry

8. Subcutaneous implantable cardioverter-defibrillator and defibrillation testing: A propensity-matched pilot study

11. SGLT2i effect on atrial fibrillation: A network meta‐analysis of randomized controlled trials.

12. Mechanical Circulatory Support Systems in the Management of Ventricular Arrhythmias: A Contemporary Overview

13. Probability Score to Predict Spontaneous Conversion to Sinus Rhythm in Patients with Symptomatic Atrial Fibrillation When Less Could Be More?

16. Toward a Uniform Ablation Protocol for Paroxysmal, Persistent, and Permanent Atrial Fibrillation

17. Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: An analysis of current clinical practice and a comparison with transvenous ICD reimplantation

18. Inherited Arrhythmias in the Pediatric Population: An Updated Overview

19. Pulsed Field Energy in Atrial Fibrillation Ablation: From Physical Principles to Clinical Applications.

20. The Feasibility, Effectiveness and Acceptance of Virtual Visits as Compared to In-Person Visits among Clinical Electrophysiology Patients during the COVID-19 Pandemic

22. Five Years of Direct Oral Anticoagulants Use in Italy: Adverse Drug Reactions from the Italian National Pharmacovigilance Network

23. The connubium among diabetes, chronic kidney disease and atrial fibrillation

24. 282 Follow-up of hospitalized COVID-19 survivors: assessment of short- and long-term cardiovascular sequelae after SARS-CoV-2 infection

27. Rationale and study design of the Italian Registry in the setting of atrial fibrillation ablation with Rivaroxaban - IRIS

28. 428 The role of virtual visits in COVID-19 cardiovascular patients

29. 269 Management of cardiac implantable electronic device follow-up in COVID-19 pandemic: lessons learned during Italian lock down

30. 427 The role of virtual visits in cardiology: from the pandemic era to future perspectives

31. 288 The effects of cardiovascular diseases and treatment on clinical course of hospitalized COVID-19 patients

32. 281 Home delivery of the communicator for remote monitoring of cardiac implantable devices: a multicentre experience during the COVID-19 lockdown

33. Rationale and study design of the Italian Registry in the setting of Atrial Fibrillation Ablation with Rivaroxaban - IRIS.

35. Home delivery of the communicator for remote monitoring of cardiac implantable devices: A multicenter experience during the covid‐19 lockdown

36. Minimal fluoroscopy approach for right‐sided supraventricular tachycardia ablation with a novel ablation technology: Insights from the multicenter CHARISMA clinical registry

38. Clinical impact of defibrillation testing in a real‐world S‐ICD population: Data from the ELISIR registry

39. Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis

40. Management of cardiac implantable electronic device follow‐up in COVID‐19 pandemic: Lessons learned during Italian lockdown

41. High-density mapping of Koch’s triangle during sinus rhythm and typical AV nodal reentrant tachycardia: new insight

42. Clinical and economic impact of multipoint left ventricular pacing: A comparative analysis from the Italian registry on multipoint pacing in cardiac resynchronization therapy (IRON‐MPP)

43. Rivaroxaban in atrial fibrillation cardioversion: an update

44. [Leadless pacing: present and future of cardiac stimulation]

45. Triggers for Atrial Fibrillation: The Role of Anxiety

46. Adverse Drug Reactions during Real-Life Use of Direct Oral Anticoagulants in Italy: An Update Based on Data from the Italian National Pharmacovigilance Network

Catalog

Books, media, physical & digital resources